484100

5-Nitro-2-(3-phenylpropylamino)benzoic Acid

Potent Cl⁻ channel blocker (IC₅₀ = 100 nM-100 µM), depending on channel subtype and assay method.

• Sinónimos: 5-Nitro-2-(3-phenylpropylamino)benzoic Acid, NPPB, CaCC Blocker II, Calcium-Activated, TMEM16 Blocker II, ANO Blocker II, Anoctamin Blocker II
• Fórmula empírica (notación de Hill): C₁₆H₁₆N₂O₄
• Número CAS: 107254-86-4
• Peso molecular: 300.31
• UNSPSC Code: 51111800
• NACRES: NA.77
• MDL number: MFCD00153851
• Assay: ≥98% (HPLC)
• Form: solid
• Storage condition: OK to freeze

Propiedades

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: solid
• manufacturer/tradename: Calbiochem^®
• storage condition: OK to freeze
• color: yellow
• solubility: DMSO: 5 mg/mL, warm ethanol: soluble
• shipped in: ambient
• storage temp.: 10-30°C
• SMILES string: [N+](=O)([O-])c1cc(c(cc1)NCCCc2ccccc2)C(=O)O
• InChI: 1S/C16H16N2O4/c19-16(20)14-11-13(18(21)22)8-9-15(14)17-10-4-7-12-5-2-1-3-6-12/h1-3,5-6,8-9,11,17H,4,7,10H2,(H,19,20)
• InChI key: WBSMIPAMAXNXFS-UHFFFAOYSA-N

Descripción

General description

Potent Cl^– channel blocker (IC₅₀ = 100 nM-100 µM), depending on channel subtype and assay method. Inhibits cyclooxygenase (IC₅₀ = 8 µM).

Potent Cl^- channel blocker (IC₅₀ = 100 nM-100 µM), depending on channel subtype and assay method. Inhibits cyclooxygenase (IC₅₀ = 8 µM).

Biochem/physiol Actions

Cell permeable: no

Primary Target
Cl⁻ channel blocker

Product does not compete with ATP.

Reversible: no

Target IC₅₀: 100 nM-100 µM as Cl-channel blocker

Other Notes

Illek, B., et al. 1992. Am. J. Physiol.263, C644.
Kirk, K., et al. 1992. J. Biol. Chem.267, 23475.
Breuer, W., et al. 1989. Biochem. Biophys. Res. Commun.163, 398.
Wangermann, P., et al. 1986. Pflugers Arch.407, S128.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)

Información de seguridad

• Clase de almacenamiento: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable